Status:
RECRUITING
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Conditions:
Testicular Cancer
Eligibility:
MALE
18-39 years
Phase:
NA
Brief Summary
This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aime...
Detailed Description
Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young adulthood. Cohort studies reveal the pr...
Eligibility Criteria
Inclusion Criteria:
- Age 18 to 39 years at time of consent
- A confirmed diagnosis of testis cancer (any stage)
- Completion of chemotherapy for testis cancer within 4 years prior to consent
- A score of >4 on the Distress Thermometer
- English fluency, as per medical record documenting preferred language or in the judgment of the investigator
- Spanish fluency, as per medical record documenting preferred language or in the judgment of the investigator
- Able to perform informed consent
Exclusion Criteria:
- Lifetime history of psychiatric of cognitive disturbance as per self-report or medical record
- In the judgment of the consenting professional, is unable to provide informed consent and complete study sessions and assessment
- As per self-report, has medical conditions that affect the immune system and would confound immune evaluation (e.g., autoimmune disorder, inflammatory disease; uncontrolled thyroid disease; active infection; myocardial infarction or stroke in the last 6 months; Type I diabetes; acute hepatitis; recent vaccination for viral disease)
- Regular smoker (daily use)
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05836688
Start Date
November 1 2023
End Date
July 1 2028
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Irvine
Irvine, California, United States, 92697-3954